Evidence map›Paper›PMID 35932013›Full record

ArticleBMC medical genomics2022

Distinct non-clock-like signatures of the basal cell carcinomas from three sisters with a lethal Gorlin-Goltz syndrome.

Lihua Ye, Li Wang, Kexin Peng, Ou Fang, Zhen Tian, Caihua Li, Xiaopeng Fu, Qingdong Chen, Jia Chen, Jing Luan and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Lihua Ye *Department of Dermatology, Haikou People's Hospital, Xiangya Medical College, Central South University, Hainan, China.
Li Wang *Department of Dermatology, Haikou People's Hospital, Xiangya Medical College, Central South University, Hainan, China.
Kexin Peng *Department of Dermatology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Ou FangGenesky Biotechnologies Inc, Shanghai, China.
Zhen TianDepartment of Dermatology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Caihua LiGenesky Biotechnologies Inc, Shanghai, China.
Xiaopeng FuDepartment of Dermatology, Haikou People's Hospital, Xiangya Medical College, Central South University, Hainan, China.
Qingdong ChenDepartment of Dermatology, Dongfang People's Hospital, Hainan, China.
Jia ChenDepartment of Dermatopathology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China.
Jing LuanDepartment of Dermatology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Zhenghua ZhangDepartment of Dermatology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. verzhang@foxmail.com.ORCID 0000-0001-9335-7022
Qiaoan ZhangDepartment of Dermatology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. zqa1976@163.com.ORCID 0000-0001-6252-5732
Fudan University · CNCentral South University · CNState Key Laboratory of Oncogene and Related Genes · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGorlin-Goltz syndrome (GS) is an inherited disease characterized by predisposition to basal cell carcinomas (BCCs) and various developmental defects, whose numerous disease-causing PTCH1 mutations have been identified in the hedgehog (Hh) signaling pathway.

methodsIn this study, whole exome sequencing was used to screen for both somatic and germline deleterious mutations in three sisters with a lethal GS. The mutations we found were confirmed by subcloning and Sanger sequencing of the genomic DNA. RNA-seq was performed to profile gene expression in paired BCCs samples and the expression levels for selected genes were validated by quantitative PCR.

resultsThe clinical and histopathologic features were analyzed for the proband in the three-generation GS family. We identified the insertion mutation PTCH1 c.1341dupA (p. L448Tfs*49), which segregated with BCC phenotype and contributed to the death of two in four patients from a Chinese family with GS. Compared with adjacent non-cancerous tissues (ANCT), four second-hit mutations were found in four of the six pairs of BCC from three patients. Of note, somatic genomic alterations in all six BCC samples were mainly clustered into non-clock-like Signature 7 (ultraviolet mutagenesis) and 11 (related to certain alkylating agents). Both RNA-seq and quantitative RT-PCR confirmed that the mRNA levels of PTCH1 and its effector GLI1 were markedly upregulated in six pairs of BCC samples versus ANCT.

conclusionsThe distinct non-clock-like signatures of BCCs indicated that GS was not a life-threatening illness. The main reasons for untimely death of GS patients were PTCH1 mutation, exposure to intense ultraviolet radiationand the poor economic conditions.

Indexed as

Basal Cell CarcinomaBasal Cell Nevus SyndromeSkin NeoplasmsHedgehog ProteinsHumansMutationHedgehog ProteinsGorlin-Goltz syndromeMutational signaturesPTCH1

Identifiers

PMID35932013
PMCPMC9354412
OpenAlexW4289868928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.